Enhancing its commitment to providing the most advanced treatment options for cancer patients through clinical trials, Rutgers Cancer Institute of New Jersey has named Sanjay Goel, MD, MS as director of its Phase I/Investigational Therapeutics Program. He is also a professor of medicine at Rutgers Robert Wood Johnson Medical School. Read more here.
Dr. Gagandeep Kang (Batch ’81) Participated in the India-US Health Partnership roundtable on “Vaccine for All”
The Indian Embassy in the United States organized a roundtable on “Vaccine for All” as part of the India-US Health Partnership. The event was conducted virtually in February 2022. The Ambassador